PUSCEDDU, SARA

PUSCEDDU, SARA  

DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)  

Mostra records
Risultati 1 - 20 di 38 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2 2023 Pusceddu, SaraNichetti, FedericoBusico, AdeleLeporati, RitaOldani, SimonePircher, Chiara CarlottaCoppa, JorgelinaMaccauro, MarcoNiger, MonicaPietrantonio, FilippoMariani, LuigiMazzaferro, VincenzoDi Liberti, Giorgiade Braud, FilippoVernieri, Claudio + Article (author) -
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 2022 Niger, MonicaNichetti, FedericoPircher, ChiaraVingiani, AndreaAgnelli, LucaPusceddu, SaraCorti, FrancescaPrisciandaro, MicheleBini, MartaPruneri, GiancarloMazzaferro, VincenzoPietrantonio, Filippode Braud, Filippo + Article (author) -
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites : Grade, mesenteric tumour deposits and emerging novelties 2021 Centonze G.Pusceddu S.Di Domenico S.Mazzaferro V. + Article (author) -
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence 2020 Pusceddu, SaraVernieri, ClaudioCoppa, JorgelinaNiger, MonicaPrisciandaro, MicheleMonteleone, MichelaDi Bartolomeo, Mariade Braud, Filppo + Article (author) -
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 2020 Pusceddu, SaraMassironi, SaraVernieri, Claudio + Article (author) -
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives 2019 Corti, FrancescaNichetti, FedericoRaimondi, AlessandraNiger, MonicaPruneri, Giancarlode Braud, FilippoPusceddu, Sara + Article (author) -
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis 2019 Petrelli, FaustoGhidini, AntonioRusso, AlessandroCostanzo, AntonioSeghezzi, SilviaGhidini, MicheleVARRICCHIO, ANTONIOCABIDDU, MARYde Braud, FilippoPusceddu, Sara + Article (author) -
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms 2019 Pusceddu, SaraCotsoglou, ChristianMazzaferro, Vincenzode Braud, FilippoPruneri, Giancarlo + Article (author) -
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis 2019 Pusceddu, SaraGhidini, MicheleCorti, FrancescaNiger, MonicaNichetti, FedericoCabiddu, Maryde Braud, FilippoPetrelli, Fausto + Article (author) -
Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETs 2019 M. MaccauroE. GaranziniF. NichettiV. MazzaferroF. BraudS. Pusceddu + Article (author) -
Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors 2019 Vernieri, ClaudioPusceddu, Sarade Braud, Filippo Article (author) -
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs) 2019 C. VernieriS. PuscedduG. FucàG. CentonzeL. CastagnoliE. FerrariA. AjaziS. CasolaM. FoianIV. MazzaferroG. PruneriF. de Braud + Article (author) -
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 2018 Pusceddu S.Barretta F.Botta L.De Braud F.Mazzaferro V.Massironi S. + Article (author) -
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. 2018 S. PuscedduC. VernieriS. MassironiF. CavalcoliV. MazzaferroF. de Braud + Article (author) -
Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumors 2017 A. PellegrinelliS. PuscedduBRAMBILLA, CECILIA ELISABETTAV. MazzaferroF. de Braud + Article (author) -
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 2017 S. PuscedduF. De Braud + Article (author) -
The underestimated role of somatostatin analogs in the NETTER-1 trial 2017 S. PuscedduF. De Braud + Article (author) -
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors 2017 Pusceddu, SaraVernieri, ClaudioCORTI, FRANCESCADe Braud, Filippo + Article (author) -
Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver 2017 CITTERIO, DAVIDES. PuscedduJ. CoppaM. BonginiF. DebraudV. Mazzaferro + Article (author) -
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential 2017 Pusceddu, SaraVerzoni, ElenaMennitto, AlessiaGrassi, PaoloVernieri, Claudio + Article (author) -